Division of Hospital Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Division of Critical Care, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
JAMA Intern Med. 2019 Feb 1;179(2):145-152. doi: 10.1001/jamainternmed.2018.5419.
Through prescription writing, dental clinicians are a potential source of initial opioid exposure and subsequent abuse for adolescents and young adults.
To examine the association between index dental opioid prescriptions from dental clinicians for opioid-naive adolescents and young adults in 2015 and new persistent use and subsequent diagnoses of abuse in this population.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study examined outpatient opioid prescriptions for patients aged 16 to 25 years in the Optum Research Database in 2015. Prescriptions were linked by National Provider Identifier number to a clinician category.
Individuals were included in the index dental opioid (opioid-exposed) cohort if they filled an opioid prescription from a dental clinician in 2015, had continuous health plan coverage and no record of opioid prescriptions for 12 months before receiving the prescription, and had 12 months of health plan coverage after receiving the prescription. Two age- and sex-matched opioid-nonexposed control individuals were selected for each opioid-exposed individual and were assigned a corresponding phantom prescription date.
Receipt of an opioid prescription within 90 to 365 days, a health care encounter diagnosis associated with opioid abuse within 365 days, and all-cause mortality within 365 days of the index opioid or phantom prescription date.
Among 754 002 individuals with continuous enrollment in 2015, 97 462 patients (12.9%) received 1 or more opioid prescriptions, of whom 29 791 (30.6%) received prescriptions supplied by a dental clinician. The opioid-exposed cohort included 14 888 participants (7882 women [52.9%], 11 273 white [75.7%], with mean [SD] age, 21.8 [2.4] years), and the randomly selected opioid-nonexposed cohort included 29 776 participants (15 764 women [52.9%], 20 078 [67.4%] white, with mean [SD] age, 21.8 [2.4] years). Among the 14 888 individuals in the index dental opioid cohort, 1021 (6.9%) received another opioid prescription 90 to 365 days later compared with 30 of 29 776 (0.1%) opioid-nonexposed controls (adjusted absolute risk difference, 6.8%; 95% CI, 6.3%-7.2%), and 866 opioid-exposed individuals (5.8%) experienced 1 or more subsequent health care encounters with an opioid abuse-related diagnosis compared with 115 opioid-nonexposed controls (0.4%) (adjusted absolute risk difference, 5.3%; 95% CI, 5.0%-5.7%). There was only 1 death in each cohort.
The findings suggest that a substantial proportion of adolescents and young adults are exposed to opioids through dental clinicians. Use of these prescriptions may be associated with an increased risk of subsequent opioid use and abuse.
通过处方开具,牙医临床医生可能是青少年和年轻成年人最初接触阿片类药物并随后滥用的潜在来源。
研究 2015 年牙科临床医生为阿片类药物初治的青少年和年轻成年人开具的牙科阿片类药物指数处方与该人群中新的持续性使用和随后滥用诊断之间的关联。
设计、设置和参与者:本回顾性队列研究检查了 2015 年 Optum Research Database 中年龄在 16 至 25 岁的门诊阿片类药物处方。处方通过国家提供者标识符号与临床医生类别相关联。
如果个体在 2015 年从牙科临床医生处获得阿片类药物处方,在接受处方前的 12 个月内有连续的健康计划覆盖且没有阿片类药物处方记录,并且在接受处方后有 12 个月的健康计划覆盖,则他们被纳入索引牙科阿片类药物(阿片类药物暴露)队列。每个阿片类药物暴露个体选择 2 名年龄和性别匹配的阿片类药物非暴露对照个体,并为其分配相应的虚拟处方日期。
在 90 至 365 天内收到阿片类药物处方、在 365 天内与阿片类药物滥用相关的医疗保健就诊诊断以及在索引阿片类药物或虚拟处方日期后 365 天内的全因死亡率。
在 2015 年连续入组的 754002 名个体中,97462 名患者(12.9%)收到 1 份或多份阿片类药物处方,其中 29791 名(30.6%)收到由牙科临床医生提供的处方。阿片类药物暴露队列包括 14888 名参与者(7882 名女性[52.9%],11273 名白人[75.7%],平均[SD]年龄为 21.8[2.4]岁),随机选择的阿片类药物非暴露队列包括 29776 名参与者(15764 名女性[52.9%],20078 名白人[67.4%],平均[SD]年龄为 21.8[2.4]岁)。在索引牙科阿片类药物队列的 14888 名个体中,1021 名(6.9%)在 90 至 365 天内收到了另一份阿片类药物处方,而 29776 名阿片类药物非暴露对照者中只有 30 名(0.1%)(调整后的绝对风险差异,6.8%;95%CI,6.3%-7.2%),866 名阿片类药物暴露个体(5.8%)经历了 1 次或多次后续与阿片类药物滥用相关的医疗保健就诊诊断,而 115 名阿片类药物非暴露对照者(0.4%)(调整后的绝对风险差异,5.3%;95%CI,5.0%-5.7%)。每个队列中只有 1 人死亡。
研究结果表明,相当一部分青少年和年轻成年人通过牙医临床医生接触到阿片类药物。这些处方的使用可能与随后阿片类药物使用和滥用的风险增加有关。